[Treatment of heparin-induced thrombocytopenia with CY 216].
Riederer
H
H
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000517:prevention & control
D000925:Anticoagulants; D006493:Heparin
Behandlung heparininduzierter Thrombozytopenien (HIT) mit CY 216.